In 2017, a patient named Anna Kuehl entered a clinical trial to test a stem cell remedy for macular degeneration. She had noticed a slow loss of vision in her left eye and as it gradually worsened, hope of avoiding loss of precious sight to age-related macular degeneration (AMD) was dimming. In the study, Kuehl was treated by principal investigator and surgeon Amir H. Kashani, MD, at the University of Southern California. As reported recently the investigational procedure worked. Kuel’s vision has greatly improved to the point that she is back to normal activities that were not possible before.
Dr. Kashani implanted a stem cell patch—an ultrathin scaffold with cells that would replace the ones that had disappeared. Imagine if this can work for large number of people facing the scary prospect of AMD. Serving as principal investigator for this clinical trial, testing a novel stem cell therapy for severe vision loss from advanced dry age-related macular degeneration, the preliminary results of this study were published in Science Translation Medicine in April 2018.
Dr. Amir H. Kishani
Amir H. Kashani, MD, PhD attended Johns Hopkins School of Medicine where he obtained both ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).